___

• Ben Hamad, M., Cornelis, F., Marzouk, S., Chabchoub, G., Bahloul, Z., Rebai, A., Fakhfakh, F., Ayadi, H., Petit-Teixeira, E., Maalej, A., 2012. Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations. Int. J. Immunogenet. 39, 131-136. oi: 10.1111/j.1744-313X.2011.01070.x. Carlström, M., Ekman, A.K., Petersson, S., Söderkvist, P., Enerbäck, C., 2012. Genetic support for the role of the NLRP3 in ammasome in psoriasis susceptibility. Exp. Dermatol. 21, 932-937. doi: 10.1111/exd.12049. Chai, W., Lian, Z., Chen, C., Liu, J., Shi, L.L., Wang, Y., 2013. JARID1A, JMY, and PTGER4 polymorphisms are related to ankylosing spondylitis in chinese han patients: A Case-Control Study. PLoS One. 8, e74794. doi: 10.1371/journal.pone.0074794. Mat, C., Yurdakul, S., Sevim, A., Özyazgan, Y., Tüzün, Y., 2013. Behçet’s syndrome: Facts and controversies. Clin. Dermatol. 31, 352-361. doi: 10.1016/j.clindermatol.2013.01.002. Direskeneli, H., 2006. Autoimmunity vs autoin ammation in Behcet’s disease: Do we oversimplify a complex disorder? Rheumatology (Oxford). 45, 1461-1465. Durães, C., Machado, J.C., Portela, F., Rodrigues, S., Lago, P., Cravo, M., Ministro, P., Marques, M., Cremers, I., Freitas, J., Cotter, J., Tavares, L., Matos, L., Medeiros, I., Sousa, R., Ramos, J., Deus, J., Caldeira, P., Chagas, C., Duarte, M.A., Gonçalves, R., Loureiro, R., Barros, L., Bastos, I., Cancela, E., Moraes, M.C., Moreira, M.J., Vieira, A.I., Magro, F., 2013. Phenotype- genotype pro les in Crohn’s disease predicted by genetic markers in autophagy-related genes (GOIA study II). In amm Bowel Dis. 19, 230-239. doi: 10.1002/ibd.23007. Glas, J., Seiderer, J., Czamara, D., Pasciuto, G., Diegelmann, J., Wetzke, M., Olszak, T., Wolf, C., Müller-Myhsok, B., Balschun, T., Achkar, J.P., Kamboh, M.I., Franke, A., Duerr, R.H., Brand, S., 2012. PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn’s disease and affect NF-κB and XBP1 binding sites. PLoS One. 7, e52873. doi: 10.1371/ journal.pone.0052873. Gül, A., 2001. Behçet’s disease: An update on the pathogenesis. Clin. Exp. Rheumatol. 19, S6-12. Kaneko, F., Togashi, A., Saito, S., Sakuma, H., Oyama, N., Nakamura, K., Yokota, K., Oguma, K., 2011. Behçet’s disease (Adamantiades-Behçet’s disease). Clin. Dev. Immunol. 2011: 681956. doi: 10.1155/2011/681956. Kaneko, F., Oyama, N., Yanagihori, H., Isogai, E., Yokota, K., Oguma, K., 2008. The role of streptococcal hypersensitivity in the pathogenesis of Behçet’s Disease. Eur. J. Dermatol. 18, 489-498. doi: 10.1684/ejd.2008.0484. Krause, I., Weinberger, A., 2008. Behçet’s disease. Curr. Opin. Rheumatol. 20, 82-87. Latiano, A., Palmieri, O., Latiano, T., Corritore, G., Bossa, F., Martino, G., Biscaglia, G., Scimeca, D., Valvano, M.R., Pastore, M., Marseglia, A., D’Incà R, Andriulli, A., Annese, V., 2011. Investigation of multiple susceptibility loci for in ammatory bowel disease in an Italian cohort of patients. PLoS One. 6, e22688. Liang, L., Tan, X., Zhou, Q., Zhu, Y., Tian, Y., Yu, H., Kijlstra, A., Yang, P., 2013. IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 in ammasome-dependent pathways is involved in ocular Behçet’s disease. Invest. Ophthalmol Vis. Sci. 54, 402-414. Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos M, Dixon, A., Demarche, B., Gut, I., Heath, S., Foglio, M., Liang, L., Laukens, D., Mni, M., Zelenika, D., Van Gossum, A., Rutgeerts, P., Belaiche, J., Lathrop, M., Georges, M., 2007. Novel Crohn disease locus identi ed by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 20;3, e58. Meggyesi, N., Kiss, L.S., Koszarska, M., Bortlik, M., Duricova, Lakatos, L., Molnar, T., Leniček, M., Vítek, L., Altorjay, I., Papp, M., Tulassay, Z., Miheller, P., Papp, J., Tordai, A., Andrikovics, H., Lukas, M., Lakatos, PL., 2010. NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World J. Gastroenterol. 16, 5233-5240. Palomino-Morales, R.J., Oliver, J., Gómez-García, M., López-Nevot, M.A., Rodrigo, L., Nieto, A., Alizadeh, B.Z., Martín, J., 2009. Association of ATG16L1 and IRGM genes polymorphisms with in ammatory bowel disease: A meta-analysis approach. Genes Immun. 10, 356-364. doi: 10.1038/gene.2009.25 Prescott, N.J., Dominy, K.M., Kubo, M., Lewis, C.M., Fisher, S.A., Redon, R., Huang, N., Stranger, B.E., Blaszczyk, K., Hudspith, B., Parkes, G., Hosono, N., Yamazaki, K., Onnie, C.M., Forbes, A., Dermitzakis, E.T., Nakamura, Y., Mans eld, J.C., Sanderson, J., Hurles, M.E., Roberts, R.G., Mathew, C.G., 2010. Independent and population-speci c association of risk variants at the IRGM locus with Crohn’s disease. Hum Mol Genet. 19, 1828-1839. doi: 10.1093/hmg/ddq041. Roberts, R.L., Hollis-Moffatt, J.E., Gearry, R.B., Kennedy, M.A., Barclay, M.L., Merriman, T.R., 2008. Con rmation of association of IRGM and NCF4 with ileal Crohn’s disease in a population-based cohort. Genes Immun. 9, 561-565. doi: 10.1038/ gene.2008.49. Roberts, R.L., Topless, R.K., Phipps-Green, A.J., Gearry, R.B., Barclay, M.L., Merriman, T.R., 2010. Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn’s disease. Genes Immun. 11, 351-356. doi: 10.1038/gene.2010.11. Seyahi, E., Tahir Turanli, E., Mangan, M.S., Celikyapi, G., Oktay, V., Cevirgen, D., Kuzuoglu, D., Ozoglu, S., Yazici, H., 2010. The prevalence of Behçet’s syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin. Exp. Rheumatol. 28, S67-75. Yang, S.K., Kim, H., Hong, M., Lim, J., Choi, E., Ye, B.D., Park, S.K., Song, K., 2011. Association of CARD8 with in ammatory bowel disease in Koreans. J Hum Genet. 56, 217-223. doi: 10.1038/jhg.2010.170.